Arkolith/Insider Trading/CTXR/Form 4

Mazur Leonard L

Chief Executive Officer, Director, 10% OwnerCitius Pharmaceuticals, Inc. (CTXR) · full profile →Form 4 · filed Apr 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 3, 2024Disposed to issuer(D)1.2M——0
Apr 3, 2024Grant(A)1.2M——1.2M

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-030811) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML